Suppression of RANKL‐dependent heme oxygenase‐1 is required for high mobility group box 1 release and osteoclastogenesis
- 16 September 2011
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 113 (2) , 486-498
Abstract
The differentiation of osteoclasts is regulated by several essential cytokines, such as receptor activator of nuclear factor κB ligand (RANKL) and macrophage colony‐stimulating factor. Recently, high mobility group box 1 (HMGB1), a chromatin protein, also has been identified as one of these osteoclast differentiation cytokines. However, the molecular mechanisms that control HMGB1 release from osteoclast precursor cells are not known. Here, we report that RANKL‐induced suppression of heme oxygenase‐1 (HO‐1), a heme‐degrading enzyme, promotes HMGB1 release during osteoclastogenesis. In contrast, induction of HO‐1 with hemin or curcumin in bone marrow‐derived macrophages or RAW‐D murine osteoclast precursor cells inhibited osteoclastogenesis and suppressed HMGB1 release. Since an inhibitor for p38 mitogen‐activated protein kinase (MAPK) prevented the RANKL‐mediated HO‐1 suppression and extracellular release of HMGB1, these effects were p38 MAPK‐dependent. Moreover, suppression of HO‐1 in RAW‐D cells by RNA interference promoted the activation of caspase‐3 and HMGB1 release, whereas overexpression of HO‐1 inhibited caspase‐3 activation as well as HMGB1 release. Furthermore, these effects were regulated by redox conditions since antioxidant N‐acetylcysteine abolished the HO‐1/HMGB1/caspase‐3 axis. These results suggest that RANKL‐dependent HO‐1 suppression leads to caspase‐3 activation and HMGB1 release during osteoclastogenesis. J. Cell. Biochem. 113: 486–498, 2012.Keywords
This publication has 44 references indexed in Scilit:
- Bone loss caused by iron overload in a murine model: importance of oxidative stressBlood, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- High-Mobility Group Box 1 Contributes to Lethality of Endotoxemia in Heme Oxygenase-1–Deficient MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- Inhibition and Genetic Deficiency of p38 MAPK Up-Regulates Heme Oxygenase-1 Gene Expression via Nrf2The Journal of Immunology, 2009
- HMGB1 Regulates RANKL-Induced Osteoclastogenesis in a Manner Dependent on RAGEJournal of Bone and Mineral Research, 2008
- RAGE Expression in Rhabdomyosarcoma Cells Results in Myogenic Differentiation and Reduced Proliferation, Migration, Invasiveness, and Tumor GrowthThe American Journal of Pathology, 2007
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Reactive oxygen species mediate RANK signaling in osteoclastsExperimental Cell Research, 2004
- Osteoclast differentiation and activationNature, 2003
- Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in miceNature Medicine, 2002